FDA 483 - ACTA Laboratories, Inc. - February 13, 2023
FDA 483 for ACTA Laboratories, Inc. on February 13, 2023. Product: drugs. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for ACTA Laboratories, Inc. on February 13, 2023. Product: drugs. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
ACTA Laboratories, Inc.Inspection Date
February 13, 2023
Product Type
drugs
ID: fd8b0370-6612-4fb9-b6b4-609d11fb0cf2
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox